Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) Non-Current Debt (2016 - 2026)

Updated

Coherus Oncology's Non-Current Debt came in at $37.25 million for Q2 2026, up 1.0% from $36.87 million a year earlier and up 0.3% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Non-Current Debt (2016 - 2026) Analysis & Trends

At the end of FY2025, Coherus Oncology's Non-Current Debt was $37.05 million, up 1.0% from FY2024.

  • Non-Current Debt carries a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
  • Going back by year, Non-Current Debt was $36.7 million in FY2024 (-85.1%), $246.48 million in FY2023 (+0.4%), $245.48 million in FY2022 (+225.1%) and $75.51 million in FY2021 (+1.4%).
  • The Q2 2026 figure represents the highest quarterly Non-Current Debt since Q1 2024.
  • Year-over-year, Non-Current Debt has increased for five consecutive quarters, with an average decline of 26.8% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Debt over five years came in Q3 2022 (growth of 323.4%), and the weakest in Q2 2024 (a decline of 85.1%).
  • Business Quant data shows CHRS's Non-Current Debt at $37.15 million (Q1 2026), $37.05 million (Q4 2025) and $36.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 37.34 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 62.48 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 23.68 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 23.83 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 60.50 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn 37.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.25 Mn
Mar 31, 2026 37.15 Mn
Dec 31, 2025 37.05 Mn
Sep 30, 2025 36.96 Mn
Jun 30, 2025 36.87 Mn
Mar 31, 2025 36.78 Mn
Dec 31, 2024 36.70 Mn
Sep 30, 2024 36.62 Mn
Jun 30, 2024 36.54 Mn
Mar 31, 2024 72.45 Mn
Dec 31, 2023 246.48 Mn
Sep 30, 2023 246.22 Mn
Jun 30, 2023 245.96 Mn
Mar 31, 2023 245.72 Mn
Dec 31, 2022 245.48 Mn
Sep 30, 2022 245.25 Mn
Jun 30, 2022 196.04 Mn
Mar 31, 2022 195.85 Mn
Dec 31, 2021 75.51 Mn
Sep 30, 2021 57.92 Mn
API Access

Coherus Oncology Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY